Comparative Effectiveness of Enteral Nutrition and Immunomodulators in Inducing and Maintaining Remission in Pediatric Crohn's Disease: A Systematic Review and Network Meta-Analysis - Takeaways - MDSpire

Comparative Effectiveness of Enteral Nutrition and Immunomodulators in Inducing and Maintaining Remission in Pediatric Crohn's Disease: A Systematic Review and Network Meta-Analysis

  • By

  • Jiajia Chen

  • Keying Yang

  • Qiongyue Zhang

  • Lijing Xiong

  • April 22, 2026

  • 0 min

Share

  • 1

    Enteral nutrition (EN) therapies, particularly exclusive enteral nutrition (EEN), are effective for inducing remission in pediatric Crohn's disease.

  • 2

    EEN demonstrated significant superiority over corticosteroids for both clinical remission induction and mucosal healing in pediatric Crohn's disease.

  • 3

    The Crohn's Disease Exclusion Diet combined with partial enteral nutrition (CDED + PEN) ranked highly for remission induction in pediatric patients.

  • 4

    Immunomodulators like azathioprine/6-mercaptopurine are essential for maintaining remission but have higher adverse event rates compared to EN therapies.

  • 5

    The findings support the use of enteral nutrition as a first-line induction therapy for pediatric Crohn's disease due to its efficacy and safety profile.

Original Source(s)

Comparative Effectiveness of Enteral Nutrition and Immunomodulators in Inducing and Maintaining Remission in Pediatric Crohn's Disease: A Systematic Review and Network Meta-Analysis

  • by Jiajia Chen, Keying Yang, Qiongyue Zhang, Lijing Xiong

  • April 22, 2026

Related Content

Distress Screening in a Cancer Survivorship Clinic: Impact on Psychosocial Referrals

This quality improvement project found that using a distress screening tool for head and neck cancer patients who were 2 or more years post-treatment led to an increased number of referrals for psychosocial needs.

Implementation of Exclusive Enteral Nutrition in Pediatric Crohn's Disease: A Secondary Analysis of the CLARA Registry Study

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors